- Start date: 1st March 2020
- End date: 30th November 2020
- Partners and collaborators: University of Leeds and University of Ghana Funders: NIHR Global Health, Policy and Systems Research Programme
Improving equitable access to essential medicines in Ghana through bridging the gaps in implementing medicines pricing policy
Ensuring availability and accessibility of medicines and supplies is an important mechanism by which national health systems equitably address the health needs of the population including the poorest and most vulnerable. In Ghana, this is a recognised policy priority. Between 2012 and 2017 the government introduced four policies to improve access to medicines through medicine price regulation, and ultimately health outcomes and quality of life. These policies, currently at different implementation stages, are: (i) supply chain master plan, (ii) framework contracting for high demand medicines, (iii) value added tax (VAT) exemptions for essential medicines and (iv) ring-fencing medicines for local manufacturing. Despite these efforts, medicine prices have remained high and continue to rise. Our core focus is therefore to understand, together with policymakers, why these presumed effective policies are not producing anticipated effects on medicine price reduction.
Study objectives and questions
Our core question is “Why are these presumed effective medicine price control policies not producing the anticipated effects in implementation in the Ghanaian context?”. More specifically, this project aims to work closely with key policymakers and other stakeholders to:
1) Develop an in-depth understanding of major determinants of effectiveness of implementing medicine pricing policies in different contexts
2) Develop a shared understanding of main facilitators and barriers to the implementation of medicine pricing policies in the Ghanaian context;
3) Drawing on the results of No1 and 2, facilitate: (a) development of a feasible action plan to improve implementation of the four key policies to improve access to essential medicines and (b) co-production of policy-relevant research agenda to address the information needs of key policymakers.
The proposed study will comprise two inter-related and overlapping phases. In the first phase, we deepen our understanding of key influences on implementation of medicines pricing policies (a) internationally, through a systematic review of key determinants of effectiveness of implementation of medicines pricing policies and (b) within Ghanaian context, through review of key policy and regulatory documents, prospective participant observations of key policy events and 15-20 in-depth interviews with key stakeholders in a situational analysis of key health systems facilitators and barriers.
The second phase, which will use results from the previous phase, will include series of consultative forums and workshops with key policymakers, managers, practitioners and communities. We envisage organising 5-6 workshops during which we will: (a) share and validate results from the systematic review and the situational analysis and then (b) co-produce, together with key decision-makers, an action plan to operationalise the implementation of the four key policies and an agenda for future research.
This project is a critical first step in our longer-term plan to improve access to essential medicines to all population groups in Ghana, through supporting the successful development, implementation, monitoring and evaluation of key policies. Ultimately, this will contribute to equitable improvements in health outcomes.
We envisage the coproduction of research agenda, continuous engagement of policy makers and implementers and getting research findings into policy and practice opportunities as being the key to our approach. Potential impact includes advanced knowledge of implementation barriers and enablers of medicine pricing strategies in different contexts, improved implementation of medicines pricing policies leading to improved access to medicines and improved health outcomes. We anticipate that improved knowledge of key determinants of successful policy implementation can be transferable across the different health-related policies in Ghana and beyond.
This study consolidates strong academic collaboration between the Nuffield Centre for International Health and Development at University of Leeds, University of Ghana (UoG) and Ghana Health Service on health systems and policy research, which will be extended into improving access to medicines by bringing the UoG’s School of Pharmacy (UGSoP).
Nuffield Centre for International Health and Development, Leeds Institute of Health Sciences, University of Leeds:
· Dr Tolib Mirzoev (Joint Principal Investigator)
University of Ghana
· Dr Augustina Koduah (Joint Principal Investigator)
Ghana Health Service, Research and Development Division
· Professor Irene Agyepong